KWAG
Kiely Wealth Advisory Group Portfolio holdings
AUM
$155M
This Quarter Return
+4.4%
1 Year Return
+7.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$158M
AUM Growth
+$158M
(-13%)
Cap. Flow
-$32.7M
Cap. Flow
% of AUM
-20.73%
Top 10 Holdings %
Top 10 Hldgs %
80.94%
Holding
315
New
13
Increased
19
Reduced
14
Closed
2
Top Buys
| 1 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
$6.86M |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
$5.94M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
$1.09M |
| 4 |
WisdomTree US MidCap Dividend Fund
DON
|
$373K |
| 5 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
$330K |
Top Sells
| 1 |
WisdomTree Floating Rate Treasury Fund
USFR
|
$35.3M |
| 2 |
iShares Treasury Floating Rate Bond ETF
TFLO
|
$10.5M |
| 3 |
Vanguard Russell 2000 ETF
VTWO
|
$1.02M |
| 4 |
Vanguard Mid-Cap Value ETF
VOE
|
$894K |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
$722K |
Sector Composition
| 1 | Technology | 3.37% |
| 2 | Financials | 2.63% |
| 3 | Consumer Discretionary | 1.98% |
| 4 | Healthcare | 1.31% |
| 5 | Consumer Staples | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARA
301
DELISTED
Paramount Global Class B
PARA
| $1.18K | ﹤0.01% | 103 | – | – |
|
302
Hawaiian Electric Industries
HE
$2.24B
| $1.01K | ﹤0.01% | 100 | – | – |
|
303
Warner Bros
WBD
$28.8B
| $913 | ﹤0.01% | 100 | – | – |
|
|
PHK
304
PIMCO High Income Fund
PHK
$851M
| $807 | ﹤0.01% | 160 | – | – |
|
305
Vontier
VNT
$6.29B
| $674 | ﹤0.01% | 17 | – | – |
|
306
RingCentral
RNG
$2.76B
| $655 | ﹤0.01% | 18 | – | – |
|
307
Exact Sciences
EXAS
$8.98B
| $556 | ﹤0.01% | 11 | – | – |
|
308
Medical Properties Trust
MPW
$2.7B
| $438 | ﹤0.01% | 100 | – | – |
|
|
CDMO
309
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $355 | ﹤0.01% | 29 | – | – |
|
|
NKLA
310
DELISTED
Nikola Corporation Common Stock
NKLA
| $173 | ﹤0.01% | 56 | – | – |
|
311
Inogen
INGN
$216M
| $137 | ﹤0.01% | 13 | – | – |
|
312
Hartford Financial Services
HIG
$37.2B
| $118 | ﹤0.01% | 1 | – | – |
|
313
ANI Pharmaceuticals
ANIP
$2.03B
| $62 | ﹤0.01% | 1 | – | – |
|
314
Boston Scientific
BSX
$156B
| – | – | -50 | Closed | -$3.77K |
|